Premium
Brain stimulation technique fails to show noninferiority to antidepressant treatment
Publication year - 2017
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30263
Subject(s) - escitalopram , mania , antidepressant , stimulation , depression (economics) , brain stimulation , medicine , deep brain stimulation , venlafaxine , transcranial direct current stimulation , adverse effect , psychology , psychiatry , neuroscience , mood , bipolar disorder , anxiety , macroeconomics , disease , parkinson's disease , economics
The noninvasive brain stimulation technique known as transcranial direct‐current stimulation (tDCS) did not demonstrate noninferiority to escitalopram in a 10‐week trial of patients with depression. The study's electrical stimulation group also experienced more adverse events, including onset of mania in two participants. Study results were published June 29 in the New England Journal of Medicine .